Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months Ra ...

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...

Stockholm - Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments in areas of high unmet medical need, announces today that it has received a Notice ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary ...

It has long been suspected that endothelial cells, the specialized cells lining the inner walls of blood vessels, play a key ...

An experimental drug repaired the gut and reversed severe fatty liver disease in animals, opening the door to a promising new ...

You can avoid a life-altering fracture in the future by adjusting your lifestyle now.

Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.

Sam Neill fought stage 3 angioimmunoblastic T-cell lymphoma, a rare type of blood cancer, but found success in treatment with a clinical trial.

NC State's defensive coordinator continues to find ways to honor his daughter after she died of cancer.

RAG-17 is an experimental RNA-targeting therapy designed to lower toxic SOD1 protein in people with SOD1-ALS. A six-person trial found RAG-17 was well tolerated, with no serious side effects. RAG-17 ...